RxDoctor Payments Data

Craig Zalvan, MD

Otolaryngology · Tarrytown, NYNPI 1790891117

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,633 of the $41,645 with a category attached, or 80.8%. Pentax Of America, Inc. accounts for 60.2% of it on its own, with 31 other manufacturers making up the rest. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,645in general payments, 2019–2025

Across 229 payments — averaging $181.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pentax Of America, Inc.$25K
  • Merz Pharmaceuticals, LLC$5K
  • Merck$5K
  • Merz North America, Inc.$2K
  • Optinose US, Inc.$843
  • Lucid Diagnostics Inc.$805
  • plus $3K from 26 others

What the payments were for

  • Consulting fees$33,63381%
  • Speaking & faculty fees$2,5056%
  • Travel & lodging$8592%
  • Food & beverage$4,64811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,645 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$529,635
Medicare patients
953
Services billed
4,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl686$15,370
Fluticasone Propionate599$7,028
Ipratropium Bromide136$4,143
Azelastine-FluticasoneAzelastine/Fluticasone21$2,073
Amitriptyline Hcl20$1,008
Famotidine73$783
Mupirocin60$552
Fluocinolone Acetonide Oil11$511
Gabapentin26$283
Tramadol Hcl24$248
CefuroximeCefuroxime Axetil14$135
Montelukast Sodium21$125

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tarrytown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →